488 related articles for article (PubMed ID: 16457645)
1. Gene therapy and targeted toxins for glioma.
King GD; Curtin JF; Candolfi M; Kroeger K; Lowenstein PR; Castro MG
Curr Gene Ther; 2005 Dec; 5(6):535-57. PubMed ID: 16457645
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy and targeted toxins for glioma.
Castro MG; Candolfi M; Kroeger K; King GD; Curtin JF; Yagiz K; Mineharu Y; Assi H; Wibowo M; Ghulam Muhammad AK; Foulad D; Puntel M; Lowenstein PR
Curr Gene Ther; 2011 Jun; 11(3):155-80. PubMed ID: 21453286
[TBL] [Abstract][Full Text] [Related]
3. Experimental therapies: gene therapies and oncolytic viruses.
Hulou MM; Cho CF; Chiocca EA; Bjerkvig R
Handb Clin Neurol; 2016; 134():183-97. PubMed ID: 26948355
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy for malignant gliomas.
Alavi JB; Eck SL
Hematol Oncol Clin North Am; 1998 Jun; 12(3):617-29. PubMed ID: 9684101
[TBL] [Abstract][Full Text] [Related]
5. Evolutionary basis of a new gene- and immune-therapeutic approach for the treatment of malignant brain tumors: from mice to clinical trials for glioma patients.
Lowenstein PR; Castro MG
Clin Immunol; 2018 Apr; 189():43-51. PubMed ID: 28720549
[TBL] [Abstract][Full Text] [Related]
6. Oncolytic viruses as experimental treatments for malignant gliomas: using a scourge to treat a devil.
Zemp FJ; Corredor JC; Lun X; Muruve DA; Forsyth PA
Cytokine Growth Factor Rev; 2010; 21(2-3):103-17. PubMed ID: 20483653
[TBL] [Abstract][Full Text] [Related]
7. Combined immunostimulation and conditional cytotoxic gene therapy provide long-term survival in a large glioma model.
Ali S; King GD; Curtin JF; Candolfi M; Xiong W; Liu C; Puntel M; Cheng Q; Prieto J; Ribas A; Kupiec-Weglinski J; van Rooijen N; Lassmann H; Lowenstein PR; Castro MG
Cancer Res; 2005 Aug; 65(16):7194-204. PubMed ID: 16103070
[TBL] [Abstract][Full Text] [Related]
8. Cell- and peptide-based immunotherapeutic approaches for glioma.
Yamanaka R
Trends Mol Med; 2008 May; 14(5):228-35. PubMed ID: 18403264
[TBL] [Abstract][Full Text] [Related]
9. Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas.
Shah AC; Benos D; Gillespie GY; Markert JM
J Neurooncol; 2003 Dec; 65(3):203-26. PubMed ID: 14682372
[TBL] [Abstract][Full Text] [Related]
10. The Potential of Cellular- and Viral-Based Immunotherapies for Malignant Glioma-Dendritic Cell Vaccines, Adoptive Cell Transfer, and Oncolytic Viruses.
Maxwell R; Luksik AS; Garzon-Muvdi T; Lim M
Curr Neurol Neurosci Rep; 2017 Jun; 17(6):50. PubMed ID: 28488122
[TBL] [Abstract][Full Text] [Related]
11. Combining cytotoxic and immune-mediated gene therapy to treat brain tumors.
Curtin JF; King GD; Candolfi M; Greeno RB; Kroeger KM; Lowenstein PR; Castro MG
Curr Top Med Chem; 2005; 5(12):1151-70. PubMed ID: 16248789
[TBL] [Abstract][Full Text] [Related]
12. Clinical trials of adenoviruses in brain tumors: a review of Ad-p53 and oncolytic adenoviruses.
Vecil GG; Lang FF
J Neurooncol; 2003 Dec; 65(3):237-46. PubMed ID: 14682374
[TBL] [Abstract][Full Text] [Related]
13. Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas.
Zhang Q; Liu F
Cell Death Dis; 2020 Jun; 11(6):485. PubMed ID: 32587256
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma.
Deng S; Zhu S; Qiao Y; Liu YJ; Chen W; Zhao G; Chen J
Protein Cell; 2014 Dec; 5(12):899-911. PubMed ID: 25411122
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of tumor antigen-specific T-cells isolated from the tumor microenvironment of sleeping beauty induced murine glioma models.
Alghamri MS; Núñez FJ; Kamran N; Carney S; Altshuler D; Lowenstein PR; Castro MG
Methods Enzymol; 2020; 631():91-106. PubMed ID: 31948569
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy for high-grade glioma.
Iwami K; Natsume A; Wakabayashi T
Neurol Med Chir (Tokyo); 2010; 50(9):727-36. PubMed ID: 20885107
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive Myeloid Cells' Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy.
Kamran N; Kadiyala P; Saxena M; Candolfi M; Li Y; Moreno-Ayala MA; Raja N; Shah D; Lowenstein PR; Castro MG
Mol Ther; 2017 Jan; 25(1):232-248. PubMed ID: 28129117
[TBL] [Abstract][Full Text] [Related]
18. [Immunotherapy in brain tumors].
De Carli E; Delion M; Rousseau A
Ann Pathol; 2017 Feb; 37(1):117-126. PubMed ID: 28111040
[TBL] [Abstract][Full Text] [Related]
19. The art of gene therapy for glioma: a review of the challenging road to the bedside.
Tobias A; Ahmed A; Moon KS; Lesniak MS
J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):213-22. PubMed ID: 22993449
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy approaches in the treatment of malignant brain tumors.
Dunn-Pirio AM; Vlahovic G
Cancer; 2017 Mar; 123(5):734-750. PubMed ID: 27875627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
